Lipo-C with B Vitamins

Lipo-C with B Vitamins: Regulatory Classification and Compliance Framework

Product Classification and Regulatory Status

This document establishes regulatory classification, authorized applications, analytical specifications, safety requirements, and appropriate handling procedures for Lipo-C with B Vitamins, a multi-nutrient lipotropic research formulation.

Product Classification Details

Product Category: Multi-nutrient lipotropic research formulation Designated Use: Experimental laboratory investigation exclusively Human Use Status: Not approved for human therapeutic application Veterinary Use Status: Not approved for animal therapeutic use Diagnostic Status: Not approved for diagnostic applications Clinical Application: Not approved for clinical use Dietary Supplement Status: Not formulated as dietary supplement Manufacturing Classification: Research-grade compound synthesis

Component Regulatory Information

Lipo-C with B Vitamins (Multi-Nutrient Formulation)

• Primary Components: L-Carnitine, L-methionine, choline, inositol, B-vitamin complex
• Modification Status: Proprietary nutrient combination
• Regulatory Status: Research use only; not FDA-approved for therapeutic use
• Safety Classification: Preclinical evaluation completed; comprehensive human safety data unavailable
• Manufacturing Standards: Research-grade synthesis and formulation protocols
• Purity Classification: Research-grade requirements (99.42% HPLC verified for batch 2025007)

Current Regulatory Status Assessment

FDA Evaluation: Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease.

Clinical Development Status: Not in clinical development. No Investigational New Drug (IND) applications submitted.

Research Designation: Classified as research reagent for qualified professional use exclusively.

International Regulatory Status: Regulatory classification varies by jurisdiction; intended for research use exclusively.

Analytical Specifications and Verification Standards

Batch Identification: 2025007

Analytical Data:

• Mass Spectrometry: 711.9 Daltons (observed molecular mass)
• HPLC Purity: 99.42%
• Primary Retention Time: 3.48 minutes
• Analytical Equipment: LCMS-7800 Series (calibration-verified)
• Secondary Peak Area: 0.58% (trace impurity profile)
• Methodology: Direct mass spectrometry and HPLC analysis

Approved Applications and Prohibited Uses

Authorized Applications:

• In vitro cell culture investigation
• Metabolic research in certified laboratory settings
• Animal model studies (institutional IACUC approval required)
• Biochemical pathway investigation
• Nutrient metabolism research
• Academic research purposes under institutional oversight

Prohibited Applications:

• Human application of any description
• Veterinary therapeutic use
• Diagnostic applications
• Clinical therapeutic administration
• Dietary supplement formulation or marketing
• Cosmetic product development
• Food or beverage fortification
• Any disease treatment, prevention, or cure claim
• Health product marketing without regulatory compliance
• Unqualified or untrained individual use
• Therapeutic health claims of any kind

Safety and Toxicology Classification

Human Safety Status: Not established. No human safety data exists. Not intended for human use.

Animal Safety Status: Limited preclinical evaluation; comprehensive safety studies not completed for this formulation.

Laboratory Safety Requirements: Standard chemical handling precautions required. Appropriate personal protective equipment mandatory.

Storage Stability Requirements: Specified storage conditions required to maintain formulation integrity and prevent degradation.

Composition and Analytical Confirmation

Active Components: Multi-nutrient lipotropic complex (proprietary combination)

• L-Carnitine
• L-Methionine
• Choline
• Inositol
• Complete B-Vitamin Complex

Observed Molecular Mass: 711.9 Daltons

Purity Classification: 99.42% (batch 2025007 HPLC analysis)

Impurity Profile: 0.58% trace secondary peak; consistent with research-grade specifications

Sterility Classification: Not sterilized; research use only

Contamination Risk: Standard laboratory precautions required for contamination prevention

Manufacturing and Quality Verification

Production Method: Multi-nutrient formulation synthesis following research-grade standards

Quality Control: HPLC and mass spectrometry verification confirming purity and identity specifications

Batch Documentation: Complete batch documentation including analytical data and specifications provided

Stability Assessment: Stability data available; formulation engineered for maintenance under appropriate storage conditions

Batch Identification: Lot designation and complete traceability maintained (Batch 2025007)

Storage and Handling Requirements

Storage Conditions: Maintain at appropriate temperature per product documentation

Environmental Requirements: Sealed container storage; protection from light and environmental contamination

Handling Procedures: Standard laboratory technique required; qualified professional use only

Shelf Life: Appropriate shelf life under specified storage conditions

User Requirements: Product restricted to trained, qualified research professionals with metabolic and biochemical investigation competency

User Liability and Responsibility

Users bear complete responsibility for appropriate handling and storage, institutional compliance, animal care protocol adherence (IACUC approval when applicable), proper waste disposal, complete record maintenance, and adverse effect reporting.

Disclaimer and Non-Approval Notification

This product has not been evaluated by regulatory authorities for safety, purity, potency, or effectiveness. It is not intended for human use, animal use, diagnostic use, or any clinical application. No therapeutic, diagnostic, or health-related claims are made or implied.

Users must understand: This is a research formulation exclusively. Safety and efficacy for therapeutic use have not been established. This product is strictly a research reagent for qualified professionals only.

Institutional Oversight Requirements

This product is intended for use exclusively within certified laboratory environments by trained and qualified research professionals under appropriate institutional oversight, including institutional biosafety committee (IBC) approval, institutional animal care and use committee (IACUC) approval for animal studies, and formal protocol review.

Regulatory Compliance Statement

Montreal Peptides Canada certifies this product is manufactured, labeled, and distributed in compliance with regulations governing research chemicals and laboratory formulations.

Regulatory Authority Contact Information

For regulatory inquiries: FDA (www.fda.gov), local institutional regulatory bodies, institutional biosafety committees, and institutional animal care committees.